Shuttle Pharmaceuticals Holdings, Inc.
18.2M
$0.74M
-0.25
$-7.16
No price alerts set. Add an alert to get notified!
-0.25
1.31
$-7.16
-519.94%
0.00%
0.00%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
AKAN
Akanda Corp.
|
$57.09 | 16.61% | -0.89 | $1.85M | 0.12 |
|
BBLG
Bone Biologics Corporation
|
$1.31 | 1.81% | -0.50 | $2.36M | 0.00 |
|
BIVI
BioVie Inc.
|
$1.68 | 1.82% | -0.76 | $12.67M | 0.02 |
|
HSCS
HeartSciences Inc.
|
$1.99 | 2.05% | -0.74 | $4.31M | 1.46 |
|
IMCC
IM Cannabis Corp.
|
$0.29 | 2.29% | -14.53 | $894,472 | 4.44 |
|
ISPC
iSpecimen Inc.
|
$5.62 | 7.46% | -0.06 | $780,404 | 0.09 |
|
MSPR
MSP Recovery, Inc.
|
$0.04 | -2.91% | -0.07 | $550,976 | -1.35 |
|
RDHL
RedHill Biopharma Ltd.
|
$1.09 | -0.46% | -0.29 | $3.61M | 0.25 |
|
TOVX
Theriva Biologics, Inc.
|
$0.39 | 8.64% | -0.19 | $13.90M | 0.17 |
|
UPC
Universe Pharmaceuticals Inc.
|
$3.21 | -0.60% | -0.49 | $1.81M | 0.16 |
* Peer stocks are selected based on market capitalization and sector
$11.25
$0.50
$0.00
0.00%
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
